---
authors:
- Ebell, Mark H
category: Case Study
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/36920834/
file_path: 2023/03/nirmatrelvir-ritonavir-reduces-hospitalization-mortality-in.md
issue: '3'
keywords:
- COVID-19
- Antiviral Agents
- COVID-19 Drug Treatment
- Ritonavir
- Humans
- Hospitalization
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Ritonavir
- COVID-19
- COVID-19 Drug Treatment
- Hospitalization
- Antiviral Agents
original_format: PubMed
pages: '316'
patient_population: Adults
peer_reviewed: true
pmid: '36920834'
processed_date: '2025-07-30'
publication_date: '2023-03-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- pubmed-enhanced
- clinical-review
- clinical-medicine
- family-practice
title: Nirmatrelvir/Ritonavir Reduces Hospitalization, Mortality in Patients 65 Years
  and Older With COVID-19; Effect on Younger Patients Unclear.
topics:
- Family Medicine
volume: '107'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '36920834'
  title: Nirmatrelvir/Ritonavir Reduces Hospitalization, Mortality in Patients 65
    Years and Older With COVID-19; Effect on Younger Patients Unclear.
  authors:
  - last_name: Ebell
    fore_name: Mark H
    initials: MH
    affiliation: University of Georgia, Athens, GA.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '107'
    issue: '3'
  publication_info:
    year: '2023'
    month: '03'
    full_date: '2023-03-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Ritonavir
    major_topic: true
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: COVID-19
    major_topic: true
  - descriptor: COVID-19 Drug Treatment
    major_topic: false
  - descriptor: Hospitalization
    major_topic: false
  - descriptor: Antiviral Agents
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  publication_types: *id001
related_articles:
- pmid: '36920834'
  title: Nirmatrelvir/Ritonavir Reduces Hospitalization, Mortality in Patients 65
    Years and Older With COVID-19; Effect on Younger Patients Unclear.
  authors:
  - name: Ebell MH
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2023 Mar
- pmid: '37103932'
  title: Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir
    and Molnupiravir Among Patients Living in Nursing Homes.
  authors:
  - name: Ma BH
    authtype: Author
    clusterid: ''
  - name: Yip TC
    authtype: Author
    clusterid: ''
  - name: Lui GC
    authtype: Author
    clusterid: ''
  - name: Lai MS
    authtype: Author
    clusterid: ''
  - name: Hui E
    authtype: Author
    clusterid: ''
  - name: Wong VW
    authtype: Author
    clusterid: ''
  - name: Tse YK
    authtype: Author
    clusterid: ''
  - name: Chan HL
    authtype: Author
    clusterid: ''
  - name: Hui DS
    authtype: Author
    clusterid: ''
  - name: Kwok TC
    authtype: Author
    clusterid: ''
  - name: Wong GL
    authtype: Author
    clusterid: ''
  source: JAMA Netw Open
  pubdate: 2023 Apr 3
- pmid: '36624705'
  title: 'Molnupiravir and Nirmatrelvir/Ritonavir: The New Available Antiviral Options
    for COVID-19.'
  authors:
  - name: Sutanto ST
    authtype: Author
    clusterid: ''
  - name: Sinto R
    authtype: Author
    clusterid: ''
  - name: Pasaribu A
    authtype: Author
    clusterid: ''
  - name: Shakinah S
    authtype: Author
    clusterid: ''
  source: Acta Med Indones
  pubdate: 2022 Oct
- pmid: '36773894'
  title: Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for
    COVID-19 survivors.
  authors:
  - name: Hsu WH
    authtype: Author
    clusterid: ''
  - name: Tsai YW
    authtype: Author
    clusterid: ''
  - name: Wu JY
    authtype: Author
    clusterid: ''
  - name: Liu TH
    authtype: Author
    clusterid: ''
  - name: Lai CC
    authtype: Author
    clusterid: ''
  source: J Infect
  pubdate: 2023 Apr
- pmid: '35245942'
  title: 'Molnupiravir and Nirmatrelvir-Ritonavir: Oral Coronavirus Disease 2019 Antiviral
    Drugs.'
  authors:
  - name: Saravolatz LD
    authtype: Author
    clusterid: ''
  - name: Depcinski S
    authtype: Author
    clusterid: ''
  - name: Sharma M
    authtype: Author
    clusterid: ''
  source: Clin Infect Dis
  pubdate: 2023 Jan 6
---

# Nirmatrelvir/Ritonavir Reduces Hospitalization, Mortality in Patients 65 Years and Older With COVID-19; Effect on Younger Patients Unclear.

**Authors:** Ebell, Mark H

**Published in:** American family physician | Vol. 107, No. 3 | 2023-03-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/36920834/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Ritonavir, COVID-19, COVID-19 Drug Treatment, Hospitalization, Antiviral Agents

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36920834/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
